Introduction {#section0005}
============

Chilo iridescent virus (CIV) is the type species for the family *Iridoviridae* ([@bib22]). The *Iridoviridae* are large, cytoplasmic DNA viruses with an icosahedral outer capsid, an internal lipid membrane, and an electron-dense core containing a circularly permuted double-stranded DNA genome (209 kbp). CIV infects a wide range of insects ([@bib45]), replicates productively in the cotton boll weevil *Anthonomus grandis* ([@bib16]), and induces metamorphic arrest and mortality in this host ([@bib33]). Earlier work showed that UV-treated CIV or viral "soluble" protein extract inhibited host protein synthesis in mosquito cells ([@bib4]). Recently, our group showed that a CIV virion protein extract (CVPE) induces mortality in neonate boll weevil larvae ([@bib1]) and apoptosis in spruce budworm *Choristoneura fumiferana* and boll weevil cell cultures ([@bib37]).

Apoptosis is generally characterized by several criteria. These include caspase activation, cytoplasmic shrinkage, phosphatidylserine exposure, chromatin condensation, DNA fragmentation, and cell blebbing ([@bib15]). Apoptosis proceeds through signal transduction pathways, usually involving activation of cysteine-aspartate-specific proteases, i.e., caspases. Various signals activate initiator (apical) caspases, which then trigger effector (executioner) caspases. In *Drosophila*, one mechanism includes interaction of Eiger (invertebrate tumor necrosis factor ligand) with the wengen membrane receptor. This leads to activation of JNK, which then triggers the central initiator caspase DRONC, instigating a cascade triggering the effector caspase Drice and ultimately apoptosis ([@bib19]). The Eiger-wengen mediated pathway appears to be the invertebrate equivalent of the "extrinsic" pathway found in mammalian systems. Alternate induction mechanisms in *Drosophila* include activation of DRONC through ER stress or through bcl-2-type stimulation and could represent invertebrate equivalents of "intrinsic" pathways. Induction of apoptosis in uninfected *Spodoptera frugiperda* (Lepidoptera: Noctuidae) cells appears to involve the equivalents of mammalian apical caspase and caspase-3 ([@bib32]) as initiator and effector caspases, respectively.

Recently, three iridoviruses from the genera *Ranavirus* and *Lymphocystivirus* were shown to induce apoptosis in cell culture ([@bib12], [@bib7], [@bib17], [@bib21]). Apoptosis induction by frog virus-3 required caspases, and induction of apoptosis by red sea bream iridovirus involved effector caspases-3 and 6 ([@bib7], [@bib21]). However, the role of viral entry and endocytosis in the induction of apoptosis by the *Iridoviridae* is not established, and the significance of viral gene expression in apoptosis modulation has not been studied.

In this report, we show for the first time that in a member of the family *Iridoviridae*: (i) entry and endocytosis of virions or virion proteins are required for apoptosis induction, (ii) apoptosis is inhibited under conditions permitting *early* viral expression, (iii) apoptosis requires the JNK signaling pathway. This is the first report of JNK signal requirement during apoptosis induction by an insect virus.

Results {#section0010}
=======

Normal and UV-treated Chilo iridescent virus induce apoptotic blebbing in spruce budworm cells {#section0015}
----------------------------------------------------------------------------------------------

To determine if CIV replication was necessary for induction of apoptosis in *C. fumiferana* (CF) cells, we treated these cells with normal and UV-inactivated CIV (CIV~UV~) as described in [Materials and methods](#sec1){ref-type="sec"}. Normal, active CIV was used at two concentrations: high dosage (CIV~XS~; 400 μg/ml) and standard dosage (CIV; 10 μg/ml). Infected cells were incubated at 28 °C as well as 21 °C for 24 h and observed for cell blebbing. [Fig. 1](#fig1){ref-type="fig"} shows that CIV~XS~ induced 70% blebbing (A), whereas CIV induced 10% blebbing and 55% lysis in these cells (B). Lysis was indicated by the presence of cell debris. CIV~UV~ (10 μg/ml) induced 62% blebbing and 5% lysis in CF cells (C). Mock-treated cells incubated at 21 °C or 28 °C did not undergo significant blebbing or lysis (D). The above results are consistent with apoptosis induction using CIV virion protein extract (CVPE) ([@bib1], [@bib37]).Fig. 1Induction of blebbing in *Choristoneura fumiferana* (CF124T) cells treated with Chilo iridescent virus and UV-treated CIV. (A) Cells treated with very large doses of CIV (400 μg/ml). (B) Cells infected with normal doses of CIV (10 μg/ml). (C) Cells treated with UV-irradiated CIV (CIV~UV~; 10 μg/ml). Incubation for panel A through panel C was at 21 °C. (D) Mock-treated cells were incubated at 21 °C or 28 °C. Observations were made by phase-contrast microscopy. Cells were photographed 24 h after infection or treatment. Magnification: 200×.

Apoptosis induced by high-dosage CIV, CVPE and UV-irradiated CIV is negated by inhibitors of caspase activity {#section0020}
-------------------------------------------------------------------------------------------------------------

To determine whether apoptosis induced by high-dosage CIV, CVPE, or UV-irradiated CIV was caspase-dependent, CF cells were pretreated with pancaspase inhibitor (Z-VAD-FMK, Calbiochem, CA) and challenged with the above inducers. Pancaspase inhibitor reduced blebbing as follows: CIV~XS~-induced by 93% ([Fig. 2](#fig2){ref-type="fig"}A), CIV~UV~-induced by 97% ([Fig. 2](#fig2){ref-type="fig"}B), CVPE-induced by 99% ([Fig. 2](#fig2){ref-type="fig"}C). To establish whether the apoptotic pathway in this system requires an apical caspase, CF cells were pretreated with Z-IETD-FMK (a mammalian caspase-8 inhibitor shown to inhibit lepidopteran, *Sf*-caspase-X) ([@bib32]) prior to challenge with CIV~XS~, CIV~UV~ or CVPE. The results show that Z-IETD-FMK blocked apoptotic blebbing by at least 97% for CIV~XS~ ([Fig. 2](#fig2){ref-type="fig"}A); 96% for CIV~UV~ ([Fig. 2](#fig2){ref-type="fig"}B); 96% for CIV~UV~; and 98% for CVPE ([Fig. 2](#fig2){ref-type="fig"}C). Mock treatment with RBSS yielded less than 2% blebbing ([Fig 2](#fig2){ref-type="fig"}D). These results suggest that apoptosis induction in CF cells by high-dosage CIV, CVPE, and UV-treated CIV is dependent on *Sf*-caspase-X-like activity, which we have designated *C. fumiferana* initiator caspase (*Cf*-caspase-i).Fig. 2Effect of pancaspase and apical caspase inhibitors on apoptosis in CF124T cells. Cells were treated with pancaspase inhibitor (Z-VAD-FMK; 50 μM), apical caspase inhibitor (Z-IETD-FMK; 50 μM), or mock-treated and then incubated at 21 °C for 24 h. Inhibitor concentrations and incubation conditions were maintained at these levels for the following. (A) Cells were pretreated with caspase inhibitors for 1 h and then treated with high doses of CIV (400 μg/ml; CIV~XS~). (B) Cells were pretreated with caspase inhibitors for 1 h and then treated with CIV~UV~ (10 μg/ml). (C) Cells were pretreated with caspase inhibitors for 1 h and then challenged with CVPE (10 μg/ml). (D) Control cells were mock-treated or treated with caspase inhibitors. Percent of the cell population showing blebbing was determined for each treatment set. Results presented are means of 4 separate experiments in which 100 cells from 5 random fields were counted. Error bars represent standard deviations of means for four experiments.

CVPE and UV-irradiated CIV induce apical caspase activity {#section0025}
---------------------------------------------------------

To confirm whether an apical enzyme is indeed activated by CVPE, UV-irradiated CIV, and CIV as suggested by the inhibitor data ([Fig. 2](#fig2){ref-type="fig"}), we tested for apical caspase activity using Caspase-Glo Assay kit (Promega, WI) as described in [Materials and methods](#sec1){ref-type="sec"}. In this assay the LETD sequence, which is specific for apical caspases, was used as substrate ([@bib28]). [Fig. 3](#fig3){ref-type="fig"} shows that CVPE increased apical caspase activity by 89% as compared to mock treatment by 24 h post-treatment. UV-irradiated CIV increased apical caspase activity by 88%, and enzyme activity in CIV-infected cells increased by 65% compared to mock treatments. These results are consistent with the caspase inhibitor data ([Fig. 2](#fig2){ref-type="fig"}) and further support a major role for an apical caspase during apoptosis induction in the CIV system.Fig. 3Activation of apical caspase in CF-124T cells treated with CVPE, CIV~UV~, or CIV. CF cells were treated with CVPE (10 μg/ml), CIV~UV~ (10 μg/ml), or CIV (10 μg/ml) and incubated at 21 °C. Cells were assayed after 24 h post-treatment for activation of apical caspase using Caspase-Glo Caspase-8 Assay Kit (Promega, WI) as per manufacturer\'s protocol. Activity is represented as % luminosity. Mock treatment was with RBSS only (bar and horizontal gray line).

JNK inhibitor negates apoptosis induction by CVPE {#section0030}
-------------------------------------------------

JNK plays an important role in regulation of *Drosophila* apoptosis through several pathways ([@bib34], [@bib25]). JNK signaling can augment or inhibit apoptosis depending on the context. Therefore, we examined the effect of JNK inhibitor in the CIV-CF cell system. [Fig. 4](#fig4){ref-type="fig"} shows that pretreatment with JNK inhibitor SP600125 (25 nM) reduced CVPE-induced apoptosis by 87%, suggesting a major role for JNK signaling in the regulation of CIV-induced apoptosis. Treatment with JNK inhibitor alone or mock treatment with Tris-NaCl buffer induced negligible blebbing.Fig. 4Effect of JNK inhibitor on CVPE-induced apoptosis. CF124T cells were pretreated with JNK inhibitor SP600125 (25 nM in Tris--NaCl, pH 7.4) for 1 h and then treated with CVPE (10 μg/ml). Cells were incubated at 21 °C for 24 h. Control cultures were mock-treated with Tris--NaCl buffer (pH 7.4) or with JNK inhibitor in Tris--NaCl buffer (pH 7.4). Bars represent percent blebbing based on counts of 200 cells per field. Error bars indicate standard deviations for four independent experiments.

Inhibition of endocytosis negates apoptosis induction by CVPE, UV-irradiated CIV and high-dose CIV {#section0035}
--------------------------------------------------------------------------------------------------

It was important to determine whether interaction of viral proteins with the cell surface in the CIV-CF cell system is sufficient for inducing apoptosis or whether there is a requirement for cellular entry. The use of ammonium chloride to inhibit acidification of endosomes in insect cells is well documented ([@bib13], [@bib20]). [Fig. 5](#fig5){ref-type="fig"}A shows that 10 mM ammonium chloride reduced apoptosis induction by CVPE (83%), CIV~UV~ (77%), and high-dose CIV (69%). [Fig. 5](#fig5){ref-type="fig"}B shows that bafilomyin A1 (1 μM), an inhibitor of endocytosis ([@bib34], [@bib30]), also reduced apoptosis induction by CVPE (93%), CIV~UV~ (93%), and high-dose CIV (91%) in CF cells. These results suggest that induction of apoptosis by CVPE, UV-irradiated CIV, or high-dose CIV is endocytosis-dependent.Fig. 5Effect of endocytosis inhibition on induction of apoptosis by CVPE, CIV~UV~, or CIV. (A) Cells were pretreated with ammonium chloride (AC; 10 mM) for 30 min prior to addition of CVPE (10 μg/ml), CIV~UV~ (10 μg/ml), or CIV~XS~ (400 μg/ml) and incubated at 21 °C for 24 h. (B) Cells were pretreated with bafilomycin A1 (Bf; 1 μM) for 30 min prior to addition of CVPE (10μg/ml), CIV~UV~ (10μg/ml), or CIV (400 μg/ml) and incubated at 21 °C for 24 h. (C) CIV~UV~ (10μg/ml) was attached to polysterene beads as described in [Materials and methods](#sec1){ref-type="sec"}. Cells were challenged with this complex, incubated at 21 °C for 24 h, and stained with safranin to differentiate between blebs and beads. Bars in plates A, B, and C represent percent blebbing based on counting 200 cells per field. Error bars indicate standard deviations for four independent experiments per set.

Virus--cell surface interaction is not sufficient for induction of apoptosis {#section0040}
----------------------------------------------------------------------------

To confirm that induction of apoptosis requires viral entry rather than surface interaction of virions with cells, we attached CIV~UV~ to polysterene beads as described in [Materials and methods](#sec1){ref-type="sec"} ([@bib36]). This would allow interaction of virions with the cell surface but preclude viral entry.

UV-treated CIV (100** **μg/ml) was attached to 12 mg polysterene beads (average diameter 10 μm) per manufacturer\'s protocol (Polysciences, Inc., PA). Beads were extensively washed after conjugation with virus, and attachment of virus to beads was confirmed using a virion-associated kinase assay. Kinase activity has been demonstrated in CIV particles ([@bib35]), and our group recently showed kinase activity in CVPE ([@bib37]). Therefore, interaction of bead-bound CIV with cells was confirmed with kinase assays on whole cells. CIV~UV~--bead conjugate and gamma ^32^P-ATP were added to cells and incubated for 1 h at 28 °C. Staurosporine and genistein were added to stop all kinase activity after incubation. The cell lysate was analyzed on SDS--PAGE and visualized by phosphorimaging. Interaction of CIV~UV~--bead conjugate with the cell surface was confirmed by the presence of at least one phosphorylated cellular protein. CIV~UV~--beads in supplemented media devoid of cells did not phosphorylate any polypeptides in the media (data not shown). Similarly, addition of gamma ^32^P-ATP to cells did not show extracellular kinase activity or blebbing. CIV~UV~ and CIV~UV~--bead conjugate were added to CF cells, incubated at 21 °C for 24 h, and assayed for cell blebbing by differentially staining the cells but not beads with Gram\'s safranin. [Fig. 5](#fig5){ref-type="fig"}C shows that polysterene-bound CIV~UV~ induced only 2% cell blebbing compared to 65% for unbound, UV-treated virus. Polysterene beads alone or conjugated with BSA induced less than 1% blebbing ([Fig. 5](#fig5){ref-type="fig"}C).

Low-pH-dependent endocytosis is required for CIV infection {#section0045}
----------------------------------------------------------

Since CVPE and CIV~UV~ required low-pH-dependent endocytosis for induction of apoptosis, we hypothesized that CIV infection should also require endocytosis. Therefore, we tested for virus replication in the presence and absence of ammonium chloride (10 mM) and bafilomyin A1 (1 μM) by observing for viral cytopathic effect and DNA replication. [Fig. 6](#fig6){ref-type="fig"} shows that CIV-induced cytopathic effect (consisting of hypertrophy, syncytia formation, granularity, or lysis) was drastically reduced in the presence of AC (85% reduction) and bafilomycin A1 (95% decrease). [Fig. 6](#fig6){ref-type="fig"} also shows that viral DNA levels (determined by dot blot analysis; see [Materials and methods](#sec1){ref-type="sec"}) in CIV infections containing AC or Bf were significantly lower (more than 95% after correction for mock infections) than those in normal CIV infections and barely above those in mock-infected cells. These results indicate that low-pH-dependent endocytosis is required for CIV infection.Fig. 6Requirement for low-pH-dependent endocytosis in CIV infection. Parallel cultures of cells were pretreated with ammonium chloride (AC; 10 mM) and bafilomycin A (Bf; 1 μM) for 30 min prior to CIV (10 μg/ml) infection, infected with CIV (10 μg/ml), or mock-treated with RBSS. Cytopathic effect (CPE) monitored was hypertrophy, syncytia formation, granularity, or lysis. Cells from parallel cultures were harvested at 48 hpi and blotted on a nitrocellulose membrane (Hybond). Viral DNA replication was detected as described in [Materials and methods](#sec1){ref-type="sec"}. Dots were quantified using ImageJ software (NIH). Mock treatments consisted of RBSS.

Pretreatment with cycloheximide augments apoptosis by CIV and CVPE {#section0050}
------------------------------------------------------------------

In order to determine whether de novo protein synthesis is required for induction of apoptosis after CIV infection, we added cycloheximide (200 μg/ml) to CF cells 1 h prior to infection. In cells with cycloheximide, CIV infection resulted in 70% apoptotic cells as determined by blebbing assay ([Fig. 7](#fig7){ref-type="fig"} ) and 60% apoptosis as determined by TUNEL assay ([Fig. 8](#fig8){ref-type="fig"} ). Similar levels of blebbing (75%) were observed when CF cells were exposed to CIV~UV~ after prior treatment with CHX (data not shown). CIV infections without inhibitor resulted in less than 10% apoptosis ([Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}B). Cycloheximide alone or mock infections resulted in less than 2% blebbing. These results indicate that de novo protein synthesis is not required for apoptosis induction upon infection of CF cells with CIV.Fig. 7Effect of cycloheximide on apoptosis induction in CIV-infected CF124T cells. Cells were treated and incubated at 21 °C for 24 h: MOCK (Tris--NaCl, pH 7.4); CHX (cycloheximide, 200 μg/ml); CIV (10 μg/ml). CF cells were pretreated with CHX for 1 h and then infected with CIV (CHX-CIV). Controls included CIV infection in the absence of CHX. Percent blebbing was determined as described in the legend for [Fig. 2](#fig2){ref-type="fig"}.Fig. 8Use of the TUNEL assay to determine the requirement for viral gene expression in the reduction of CIV-induced apoptosis. (A) CF124T cells treated with cycloheximide (CHX; 200 μg/ml) 1 h prior to infection with CIV (10 μg/ml); (B) CIV-infected cells without CHX treatment; (C) uninfected CHX-treated cells. Cells were incubated at 21 °C, observed 24 h after treatment, and processed for TUNEL assay as described in [Materials and methods](#sec1){ref-type="sec"}.

Viral early expression inhibits CIV-induced apoptosis {#section0055}
-----------------------------------------------------

CIV infection induces a much lower level of apoptosis in CF cells than CIV~XS~, CVPE, or CIV~UV~ ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}). Moreover, inhibition of viral protein synthesis enhances CIV-induced apoptosis, suggesting that CIV gene expression is required for suppression of apoptosis. To determine if viral early gene expression blocks apoptosis induction upon CIV infection, we pretreated CF cells with aphidicolin (5 μg/ml) ([@bib10]) or with phosphonoacetic acid (PAA; 200 μg/ml) prior to infection. [Fig. 9](#fig9){ref-type="fig"} shows that CIV infection induced only 2% blebbing in the presence of aphidicolin and 1% blebbing with phosphonoacetic acid pretreatment compared to 10% during CIV infections of untreated cells. Thus, blebbing levels are significantly lower under conditions permitting only early gene expression compared to those allowing both early and late gene expression. Late gene expression down regulates many early genes in CIV ([@bib11]), which probably leads to the observed 10% enhancement of blebbing. [Fig. 9](#fig9){ref-type="fig"} also shows that inhibition of viral DNA replication in CIV infections where CIV~UV~ or CVPE had been added as apoptosis inducers resulted in similarly drastic reductions in apoptotic blebbing. Cells challenged with CIV and CIV~UV~ together (data not shown) manifested blebbing in 65% of the cell population, probably due to an overwhelming dose of viral proteins. Reciprocal experiments involving CVPE treatment for 1 h followed by CIV and PAA resulted in 40% blebbing and 35% cell lysis, probably due to excessive dose of viral proteins (data not shown). These results suggest that one or more viral early gene products inhibited apoptosis induction by CIV, CVPE, or CIV~UV~.Fig. 9Effect of early viral gene expression on apoptosis induction by CIV~UV~ and CVPE in CF124T cells. Late gene expression in CIV-infected CF124T cells was blocked by inhibiting viral DNA replication with 5 μg/ml aphidicolin (APH) or 200 μg/ml phosphonoacetic acid (PAA). Viral early gene expression was permitted for 6 h after infection with CIV (10 μg/ml), and cells were challenged with CIV~UV~ (10 μg/ml) or with CVPE (10 μg/ml). Cells were then incubated at 21 °C and observed for apoptotic blebbing 24 h after initial treatment or infection. MOCK: untreated cells; APH/PAA: cells treated with aphidicolin or phosphonoacetic acid, respectively; CIV~UV~/CVPE: cells treated with CIV~UV~ only (A1, B1) or with CVPE only (A2, B2); CIV-APH/PAA and CIV~UV~/CVPE: cells pretreated with APH or PAA, infected with CIV, then challenged with CIV~UV~ (A1, B1) or CVPE (A2, B2) at 6 hpi. Results presented are means of 3 separate experiments in which 100 cells from 5 random fields were counted. Error bars represent standard deviations.

CIV early gene expression inhibits apical caspase activity {#section0060}
----------------------------------------------------------

Since CIV early gene expression blocked apoptosis, it was important to determine the effect of this temporal phase on apical caspase activity (putative *Cf*-caspase-i) vital to apoptosis induction in this system ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}). Therefore, we assayed *Cf*-caspase-i activity in CF cells at 24 h post-infection (or treatment) under conditions allowing early but not late viral expression. [Fig. 10](#fig10){ref-type="fig"} shows that significant levels of apical caspase activity were detected in CIV infections with or without inhibition of early gene expression with cycloheximide (CHX-CIV; CIV) and in cells treated with CIV virion protein extract (CVPE). On the other hand, when phosphonoacetic acid restricted viral expression to early genes, CIV infection suppressed *Cf*-caspase-i activity to mock infection levels ([Fig. 10](#fig10){ref-type="fig"}: CIV-PAA). Challenge of CIV-PAA with CVPE did not induce *Cf*-caspase-i activity ([Fig. 10](#fig10){ref-type="fig"}: CIV-PAA-CVPE), indicating strong inhibition of this pathway by viral early gene expression. *Cf*-caspase-i activity was very low at 3 h post-CIV infection ([Fig. 10](#fig10){ref-type="fig"}: CIV-3HPI), which is within the immediate-early phase of the CIV replication cycle ([@bib11]). On the other hand, *Cf*-caspase-i activity 3 h after CVPE treatment was high ([Fig 10](#fig10){ref-type="fig"}: CVPE-3HPT). *Cf*-caspase-i levels at initiation of infection or treatment were at mock infection levels. These data strongly suggest that one or more factors expressed during the early temporal phase of the CIV gene expression program inhibit *Cf*-caspase-i activity.Fig. 10Effect of CIV early gene expression on activation of apical caspase. CF124T cells were assayed for caspase-8 activity after treatment with CVPE. Incubation was at 21 °C for 24 h except where noted. Reagents and inhibitors were in RBSS at the following concentrations: CIV (10 μg/ml), phosphonoacetic acid (PAA; 200 μg/ml), cycloheximide (CHX; 200 μg/ml), and CVPE (10 μg/ml). CHX: treatment with cycloheximide alone. CHX-CIV: cells pretreated with CHX and infected with CIV compared to treatment with CHX only. PAA: phosphonoacetic acid-treated cells. CIV-PAA: cells pretreated with PAA and infected with CIV. CIV-PAA-CVPE: cells pretreated with PAA, infected with CIV, and then challenged with CVPE after 6 hpi. CIV: cells infected with CIV (10 μg/ml) at 24 hpi. CVPE 3HPT: cells treated with CVPE and assayed at 3 h post treatment. CIV 3HPI: apical caspase assay carried out 3 h after infection with CIV compared to CVPE 3HPT. CVPE: cells treated with CVPE alone. Caspase-8 assay was carried out as described in [Materials and methods](#sec1){ref-type="sec"}. Values indicated are relative luminosity units. MOCK treatment was with RBSS only (bar and horizontal gray line). Values for all treatments at *t* = 0 were not significantly different from mock treatments. Error bars represent standard deviations for 3 independent experiments.

Discussion {#section0065}
==========

We previously showed that Chilo iridescent virus capsid protein extract (CVPE) induced apoptosis and inhibition of host protein synthesis in *C. fumiferana* (IPRI-CF-124T) and *A. grandis* (BRL-AG-3A) cells ([@bib1], [@bib37]). In the present report, we demonstrate that apoptosis induction upon infection with CIV or treatment with virion components requires endocytosis, is strongly suppressed by viral early expression, does not require de novo viral protein synthesis, and is dependent on apical caspase and JNK-like factors. These are the first such findings for a member of the family *Iridoviridae*.

Induction of profuse apoptotic blebbing with very high doses of CIV (400μg/ml) probably results from virion components initiating rapid apoptosis, which preempts viral gene expression and consequent viral replication. These results are consistent with our observation that UV-irradiated CIV is capable of inducing apoptosis in CF cells. The ability of UV-irradiated cytoplasmic DNA viruses to induce apoptosis varies with virus and cell type ([@bib15]).

Low-pH-dependent endocytosis of CVPE and of UV-irradiated CIV was necessary for induction of apoptosis, implicating a requirement for cellular entry. This was further supported by preclusion of cellular entry when CIV~UV~ was attached to polysterene beads and concurrent abolition of apoptotic activity ([Fig. 5](#fig5){ref-type="fig"}). Binding of CVPE and CIV~UV~ to polysterene beads did not present steric hindrance problems as determined by the ability of virion-associated kinase activity to phosphorylate at least one cellular polypeptide. The requirement for cellular entry in induction of apoptosis has been shown for other cytoplasmic DNA viruses such as African swine fever virus (ASFV) ([@bib3]) and vaccinia virus ([@bib38]). Several viruses outside this group also require cellular entry as a prerequisite for apoptosis induction. These include *Autographa californica* nucleopolyhedrovirus (AcMNPV) ([@bib26]), Sindbis virus ([@bib24]), human reovirus ([@bib8]), and murine coronavirus ([@bib29]).

The JNK pathway plays a critical role in insect immunity. JNK (coded by basket in *Drosophila*) ([@bib39], [@bib41]) is activated upon infection of lepidopteran ([@bib46]) and *Drosophila* species ([@bib25]). In *Drosophila*, Eiger (invertebrate tumor necrosis factor; TNF) functions as a cell death ligand and binds to the TNF receptor-like protein, wengen. Eiger requires the JNK pathway and the mammalian caspase-9 homologue DRONC, which it activates ([@bib19]). JNK-mediated proapoptotic action does not always require gene expression ([@bib27]).

Our data show that JNK and apical caspase inhibitors each block CIV-induced apoptosis in *C. fumiferana* cells, and this is consistent with the general scheme outlined for apoptosis in *Drosophila.* Therefore, as summarized in [Fig. 11](#fig11){ref-type="fig"} , we postulate that Z-IETD-FMK inhibits a DRONC-like caspase (*Cf*-caspase-i) to suppress apoptosis ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}) in CF cells. The JNK inhibitor, SP600125, blocks JNK activity and impedes DRONC-mediated apoptosis in CF cells ([Fig. 4](#fig4){ref-type="fig"}). Preliminary data (not shown) indicate that JNK inhibitor also inhibits caspase *activity*, suggesting that JNK is upstream of apical caspase activation. Thus, the suppression of apoptosis by inhibitors of apical caspase and JNK underscores the importance of the JNK signaling pathway in iridovirus-induced apoptosis.Fig. 11Model for apoptosis regulation in CIV-infected *C. fumiferana*, CF-124T cells. Virion proteins induce apoptosis via a putative *C. fumiferana* apical caspase (designated *Cf*-caspase-i) after endocytic entry. Endocytosis is required for CIV infection. Note: processes compromised by addition of inhibitor are indicated in gray. During CIV infection, early gene expression inhibits *Cf*-caspase-i activity and reduces apoptosis. Blocking early viral expression raises activation of *Cf*-caspase-i activity and consequent apoptosis. JNK and apical caspase inhibitors each hinder CIV-induced apoptosis in *C. fumiferana* cells ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}). In this model, Z-IETD-FMK inhibits a DRONC-like caspase (*Cf*-caspase-i) resulting in cell survival; additionally, JNK inhibitor SP600125 impedes DRONC-mediated apoptosis, thus promoting cell survival.

An "extrinsic" pathway has been postulated for lepidopteran, *S. frugiperda* cells (IPLB-SF-21), based on the induction of apoptosis by mammalian FADD and TNFα, which utilize caspase-8 in mammalian systems ([@bib43], [@bib31]). A putative apical caspase designated *Sf*-caspase-X is inhibited by Z-IETD-FMK in *S. frugiperda* cells ([@bib32]). Our data show that Z-IETD-FMK also blocks CVPE-induced apoptosis ([Fig. 3](#fig3){ref-type="fig"}) and suggest that CVPE-induced apoptosis in *C. fumiferana* cells is mediated through a putative apical caspase, designated *C. fumiferana* initiator caspase (*Cf*-caspase-i). There is some evidence that caspase-8 homologue (DREDD) and FADD homologue (DFADD) detected in *Drosophila* may be contributing to the apoptotic process in insects ([@bib6], [@bib18]); however, this is not firmly established. On the other hand, it is well established that DRONC plays a central role in *Drosophila* apoptosis as well as metamorphosis and could well be the common conduit for all caspase-dependent apoptosis in insect systems ([@bib44], [@bib14]). It should also be noted that CVPE as well as CIV induce metamorphic arrest and mortality in the cotton boll weevil ([@bib1]). Given this and the relationship between the JNK pathway and DRONC in *Drosophila*, we postulate that Z-IETD-FMK suppresses apoptosis in the CIV-CF cell system by inhibiting putative DRONC-like *Cf*-caspase-i ([Fig. 11](#fig11){ref-type="fig"}).

We have provided strong evidence suggesting inhibition of apoptosis by one or more viral early gene products. CIV virion protein extract (CVPE) and UV-irradiated CIV induced strong apoptosis as observed by blebbing and TUNEL assays, but induction of apoptosis with infectious CIV was muted. Induction by CVPE, CIV~UV~, or CIV in the presence of CHX suggests that CIV gene expression or DNA replication was not required for apoptosis ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}). Suppression of apoptosis under conditions that permit early but not late gene expression ([Fig. 9](#fig9){ref-type="fig"}) and enhancement of apoptosis under conditions that block early gene expression ([Fig. 10](#fig10){ref-type="fig"}) further support these findings. Muted apoptosis with infectious CIV ([Fig. 7](#fig7){ref-type="fig"}) may be due to expression of *iap*-like genes documented in the CIV genome, viz ORF 157L (L), ORF 193R (IDL), ORF 332L (IL), and ORF 284R (L) ([@bib23], [@bib11]). The first three of these ORFs are similar to *iap genes* in *Cydia pomonella* granulosis virus (CpGV; ([@bib9]) and have the following motifs, respectively: ring finger, BIR repeat profile, and bipartite nuclear localization signal. ORF 284R is similar to an ASFV gene coding for a polypeptide (p27) with an IAP domain ([@bib5]) and is expressed exclusively at *late* times in CIV infections ([@bib11]). The temporal status of ORFs 157L, 193R, and 332L are not known, but published data do not preclude an immediate-early status for ORF 193R or ORF 332L ([@bib11]). IAP genes, dIAP 1--3, are described in *Drosophila* where they inhibit caspase-9 homologue, DRONC, and *Drosophila* tumor necrosis factor receptor-associated factor 1, dTraf1. Our data do not preclude early expression of a CIV gene product other than *iap* that inhibits apical caspase activity and either blocks apoptosis or recruits cellular factors for this purpose ([@bib40]).

Taken together, our results show that, in response to entry of CIV or virion proteins, *C. fumiferana* cells undergo apoptosis through direct or indirect activation of JNK (and therefore the MAP kinase pathway) and caspases, possibly involving the putative apical caspase, *Cf*-caspase-i. However, upon *infection* with CIV, this response is rapidly and significantly inhibited by viral early gene expression. Excessive viral load overwhelms control mechanisms, resulting in profuse, immediate apoptosis. [Fig. 11](#fig11){ref-type="fig"} depicts a working model incorporating our data. This is the first report showing that endocytosis and JNK-like activity are essential components of the apoptotic pathway in a member of the family *Iridoviridae* and that apoptosis in this virus group is suppressed by early viral expression. This is also the first report of JNK signal requirement during apoptosis induction by an insect virus.

Materials and methods {#sec1}
=====================

Virus rearing and purification {#section0070}
------------------------------

Chilo iridescent virus was raised in larvae of the greater wax moth *Galleria mellonella* and purified by sucrose gradient centrifugation as described previously ([@bib16]).

Cell culture {#section0075}
------------

IPRI-CF-124T (CF) cells ([@bib2]) from the spruce budworm *C. fumiferana* and BRL-AG-3A (AG) cells ([@bib42]) from the boll weevil *A. grandis* were cultured in Corning 25-cm^2^ flasks using Hink\'s TNM-FH medium supplemented with 10% fetal bovine serum (HyClone laboratories) and incubated at 28 °C**.** CF and AG cells were typically subcultured at 6-day intervals at a ratio of 1:10 ([@bib16]).

Virus infections {#section0080}
----------------

IPRI-CF-124T cells (7.5 × 10^5^ cells/ml) in 24-well plates (Corning) were inoculated with suspensions of purified CIV at 10 μg/ml in unsupplemented medium. TCID~50~ assays developed in our laboratory indicated that 10 μg/ml of purified CIV represents 10^9^ IU/ml (D\'Costa, S. M., Perales, M., and Bilimoria, S. L., unpublished data). Cells were washed and inoculum was adsorbed as described previously ([@bib10]). Infected cultures were incubated at 21 °C. Mock-infected cells were treated as above with inoculum devoid of virus.

Preparation of CIV protein extract {#section0085}
----------------------------------

CHAPS \[3-(3-chloamidopropyl) dimethylamino-1-propanesulfonate\] (Sigma-Aldrich, St. Louis, MO) were used to prepare CIV protein extract (CVPE) from purified virions by a procedure modified from [@bib4] and described by [@bib37].

Blebbing assay {#section0090}
--------------

Blebbing assays were carried out as described by [@bib37]. Actinomycin D (4 μg/ml) was used as positive control and heat-inactivated CVPE (65 °C for 30 min) was the negative control. Experiments were performed in triplicate and percentages of cells showing blebs were calculated.

UV-irradiated virus {#section0095}
-------------------

CIV (2 ml at 1.6 mg/ml) was added to 60-mm^2^ plates (Corning) and exposed to UV radiation (254 nm) using a 60-watt germicidal UV lamp (Contamination Control Inc.) at a distance of 10 cm for 45 min. UV inactivation of CIV was confirmed by testing CF cells infected with normal and UV-irradiated CIV (CIV~UV~) for viral DNA replication by dot blot analysis ([@bib10]) and quantification of blots by scintillation counting. CF cells were infected with CIV~UV~ and CIV at normal (10 μg/ml) and excess (400 μg/ml; CIV~XS~) doses. To determine the effect of infection with CIV~UV~ vs. CIV, 10 μg/ml of each virus preparation was added to 24-well plates seeded with CF cells, incubated at 21 °C for 18 h and observed by phase-contrast microscopy for cytopathic effect (hypertrophy, syncytia formation, granularity or lysis) or apoptotic blebbing.

Caspase inhibitor treatments {#section0100}
----------------------------

Pancaspase inhibitor Z-VAD-FMK or caspase-8 inhibitor (Z-IETD-FMK; Calbiochem, CA) was used as appropriate to inhibit caspase activities. CF cells were seeded in either 24-well or 60-well plates (Corning). Cells were incubated with pancaspase inhibitor (50 μM), caspase-8 inhibitor (50 μM), or JNK inhibitor SP600125 (25 nM) for 1 h at 28 °C. These cells were then challenged with either CVPE (10 μg/ml), CIV (400 μg/ml), or CIV~UV~ (10 μg/ml) and incubated for an additional 24 h. The percent of cell population undergoing blebbing was monitored as described above.

Apical caspase enzyme assay {#section0105}
---------------------------

IPRI-CF-124T cells (7.5 × 10^5^ cells/ml) in 24-well plates (Corning) were inoculated with CVPE (10 μg/ml), CIV (10 μg/ml), or CIV~UV~ (10 μg/ml) for 24 h at 21 °C. Caspase-8 assay was carried out using the Caspase-Glo Caspase-8 Assay Kit (Promega, WI) as per manufacturer\'s protocol. Relative luminescence was measured with a Reporter microplate luminometer (Turner Designs, CA).

TUNEL assay {#section0110}
-----------

The TUNEL assay (terminal deoxynucleotidyl transferase \[TdT\]-mediated dUTP nick-end labeling) was carried out using the TdT-FragEL DNA fragmentation detection kit, Calbiochem (Cambridge, MA) as described by [@bib37]. Five randomly selected fields were counted per slide, and percentages of TUNEL-positive cells (brown nuclei) were calculated from a sample size of at least 100 cells.

Ammonium chloride (AC) and bafilomycin A1 (Bf)-mediated inhibition of endocytosis {#section0115}
---------------------------------------------------------------------------------

CF cells (6.3 × 10^5^ cells/ml complete TNM-FH) were seeded at 400 μl per well in Corning 24-well trays. Cells were pretreated with ammonium chloride (10 mM) or bafilomycin A1 (1 μM) for 30 min prior to addition of CVPE (10 μg/ml) and UV-treated CIV (10μg/ml; see above) then incubated at 28 °C for 24 h. The concentrations of AC and Bf were maintained at 10 mM and 1 μM, respectively, through the treatment phase.

CIV replication {#section0120}
---------------

CF cells (6.3 × 10^5^ cells/ml complete TNM-FH) were seeded at 400 μl per well in Corning 24-well trays. Parallel sets of cells were pretreated with ammonium chloride (10 mM) or bafilomycin A (1 μM) for 30 min prior to CIV infection or not treated. Cells were incubated at 21 °C for 48 h. Hypertrophy, syncytia formation, granularity, or lysis indicated CPE. Cell monolayers were lysed with 0.5 M NaOH. Suspensions were neutralized with 10 M ammonium acetate and blotted on nitrocellulose membrane using a dot-blot apparatus (Bio-Rad). Dot blotting was carried out as described previously ([@bib10]).

Preparation of polysterene-linked UV-treated CIV {#section0125}
------------------------------------------------

UV-treated CIV (100** **μg/ml) was attached to 12 mg polysterene beads (average diameter 10 μ) per manufacturer\'s protocol (Polysciences, Inc., PA) except that sodium azide was omitted to prevent cell toxicity. Beads were extensively washed after conjugation with virus. Viral attachment to beads was confirmed using the assay for a kinase demonstrated in CIV particles ([@bib35]) and recently detected in CVPE ([@bib37]). The amount of CIV~UV~ conjugated with beads was determined using the Bradford assay. Interaction of bead-bound CIV was confirmed with kinase assays on whole cells. CIV~UV~--bead conjugate (10 μg protein/ml) and gamma ^32^P-ATP (10 μM) were added to cells. (ATP cannot traverse the cell membrane.) Cells were incubated at 28 °C for 1 h and washed thoroughly. Staurosporine (1 μM) and genistein (50 μM) were added to stop all kinase activity after incubation. The cell lysate was run on SDS--PAGE and analyzed by phosphorimaging. Interaction of CIV~UV~--bead conjugate with the cell surface was confirmed by the presence of at least one phosphorylated cellular protein. CIV~UV~ (10 μg/ml) and CIV~UV~--bead conjugate (10 μg protein/ml) were added to CF cells, incubated at 28 °C for 24 h, and assayed for cell blebbing by staining for cells with Gram\'s safranin for 2 min.
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